For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

the metabolites they measured might help predict and perhaps even treat diabetes. “Our study suggests a potential mechanism to explain why sugar-sweetened beverages are bad for your metabolism ...

GLP-1 agonists are widely used to manage type 2 diabetes and obesity. These medications help lower blood sugar levels, promote weight loss, and support heart health, making them a popular choice ...

NEW YORK, Jan 22 — A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts ...

PARIS, France — A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including dementia and cardiovascular diseases, although experts ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have ...

including several newly found conditions linked to the GLP-1 class of weight loss and diabetes drugs. However, the new study led by Ziyad Al-Aly, a physician-scientist at the Veterans Affairs St ...

with an array of celebrity endorsements that hail the help they provide for both Type 2 diabetes and obesity. And Wegovy has been approved by the U.S. Food and Drug Administration for use in people ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, ...